Methadone

The WSMA supports the use of methadone maintenance as crucial in the treatment of opiate dependency and to decrease the spread of HIV infection. The WSMA supports legislation assuring rapid access to comprehensive methadone treatment for those who request or are referred for such treatment. The WSMA supports adequate funding for such therapy. (Res 9, C-91) (Reaffirmed A-17)

The WSMA supports changes in laws and regulations which currently prevent physicians who are deemed qualified by the medical profession from providing treatment for opiate addicted patients. (EC Rpt J, A-96) (Reaffirmed A-17)

The WSMA supports increasing the interval between take-home methadone distributions for maintenance and detoxification treatment, per provider discretion, similar to the COVID-era extension policy created by the Substance Abuse and Mental Health Services Administration (SAMHSA). (B-9, A-21)

RESOLVED, the WSMA will utilize the “Good Guidance” petition process to request SAMHSA modify current policy to reflect the COVID-19 era policy on take-home methadone doses, including for pregnant and parenting patients. (B-9, A-21)

Return to the WSMA Policy Compendium index

Abbreviations for House of Delegates report origination:

EC – Executive Committee; BT – Board of Trustees; CPA – Council on Professional Affairs; JC – Judicial Council; CHS – Community and Health Services